• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Current management of uncomplicated ascites.

作者信息

Angeli Paolo

机构信息

Unit of Hepatic Emergencies and Liver Transplantation, Department of Medicine, University of Padova, Padova, Italy.

出版信息

Clin Liver Dis (Hoboken). 2013 Jun 21;2(3):125-127. doi: 10.1002/cld.193. eCollection 2013 Jun.

DOI:10.1002/cld.193
PMID:30992843
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6448635/
Abstract
摘要

相似文献

1
Current management of uncomplicated ascites.单纯性腹水的当前管理。
Clin Liver Dis (Hoboken). 2013 Jun 21;2(3):125-127. doi: 10.1002/cld.193. eCollection 2013 Jun.
2
[Clinical guidelines for diagnosis and treatment of ascites. Therapeutic aspects of management of uncomplicated ascites.].[腹水诊断与治疗临床指南。单纯性腹水管理的治疗方面。]
Rev Gastroenterol Mex. 2009 Oct-Dec;74(4):392-5.
3
The management of ascites and hyponatremia in cirrhosis.肝硬化腹水和低钠血症的管理
Semin Liver Dis. 2008 Feb;28(1):43-58. doi: 10.1055/s-2008-1040320.
4
[Guidelines for diagnosis and management of cirrhotic ascites and its complications. The Israeli Association for the Study of the Liver].[肝硬化腹水及其并发症的诊断与管理指南。以色列肝脏研究协会]
Harefuah. 2012 Dec;151(12):705-8, 719.
5
Usefulness of ascites/serum lactic dehydrogenase activity ratio in the initial approach to ascites.腹水/血清乳酸脱氢酶活性比值在腹水初步诊断中的应用价值
Arq Gastroenterol. 1991 Apr-Jun;28(2):47-51.
6
Translating Our Current Understanding of Ascites Management into New Therapies for Patients with Cirrhosis and Fluid Retention.将我们目前对腹水管理的认识转化为针对肝硬化和液体潴留患者的新疗法。
Dig Dis. 2017;35(4):402-410. doi: 10.1159/000456595. Epub 2017 May 3.
7
Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver.
Ital J Gastroenterol Hepatol. 1999 Oct;31(7):626-34.
8
HEP-Net opinion on the management of ascites and its complications in the setting of decompensated cirrhosis in the resource constrained environment of Pakistan.HEP-Net关于在巴基斯坦资源有限环境下失代偿期肝硬化患者腹水及其并发症管理的意见。
Pak J Med Sci. 2020 Jul-Aug;36(5):1117-1132. doi: 10.12669/pjms.36.5.2407.
9
Management of uninfected and infected ascites in cirrhosis.肝硬化患者未感染性腹水和感染性腹水的管理。
Liver Int. 2016 Jan;36 Suppl 1:109-15. doi: 10.1111/liv.13015.
10
Ascites and Hepatorenal Syndrome.腹水和肝肾综合征。
Clin Liver Dis. 2019 Nov;23(4):659-682. doi: 10.1016/j.cld.2019.06.002. Epub 2019 Aug 7.

本文引用的文献

1
EASL clinical practice guidelines on the management of ascites, spontaneous bacterial peritonitis, and hepatorenal syndrome in cirrhosis.欧洲肝脏研究学会肝硬化腹水、自发性细菌性腹膜炎和肝肾综合征管理临床实践指南
J Hepatol. 2010 Sep;53(3):397-417. doi: 10.1016/j.jhep.2010.05.004. Epub 2010 Jun 1.
2
Combined versus sequential diuretic treatment of ascites in non-azotaemic patients with cirrhosis: results of an open randomised clinical trial.联合与序贯利尿剂治疗非氮质血症肝硬化腹水患者的随机开放临床试验结果。
Gut. 2010 Jan;59(1):98-104. doi: 10.1136/gut.2008.176495.
3
Spironolactone alone or in combination with furosemide in the treatment of moderate ascites in nonazotemic cirrhosis. A randomized comparative study of efficacy and safety.螺内酯单用或与呋塞米联用治疗非氮质血症性肝硬化中度腹水：一项疗效与安全性的随机对照研究
J Hepatol. 2003 Aug;39(2):187-92. doi: 10.1016/s0168-8278(03)00188-0.
4
The management of ascites in cirrhosis: report on the consensus conference of the International Ascites Club.肝硬化腹水的管理：国际腹水俱乐部共识会议报告
Hepatology. 2003 Jul;38(1):258-66. doi: 10.1053/jhep.2003.50315.
5
Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.比较白蛋白、右旋糖酐70和聚明胶肽用于肝硬化腹水患者腹腔穿刺治疗的随机试验。
Gastroenterology. 1996 Oct;111(4):1002-10. doi: 10.1016/s0016-5085(96)70068-9.
6
Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascites.氨氯吡咪和螺内酯钾对非氮质血症肝硬化腹水患者疗效的随机临床研究
Hepatology. 1994 Jan;19(1):72-9.
7
Randomized comparative study of efficacy of furosemide versus spironolactone in nonazotemic cirrhosis with ascites. Relationship between the diuretic response and the activity of the renin-aldosterone system.速尿与螺内酯治疗非氮质血症性肝硬化腹水疗效的随机对照研究。利尿反应与肾素-醛固酮系统活性之间的关系。
Gastroenterology. 1983 May;84(5 Pt 1):961-8.
8
Compartmentalization of ascites and edema in patients with hepatic cirrhosis.肝硬化患者腹水和水肿的分隔化
N Engl J Med. 1970 Jun 18;282(25):1391-6. doi: 10.1056/NEJM197006182822502.
9
Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites.血浆醛固酮浓度对肝硬化腹水患者螺内酯利钠作用的重要性。
Digestion. 1985;31(4):189-93. doi: 10.1159/000199198.
10
Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study.腹腔穿刺术与利尿剂治疗肝硬化腹水患者的比较：一项随机研究的结果
Gastroenterology. 1987 Aug;93(2):234-41. doi: 10.1016/0016-5085(87)91007-9.